Predicting Prognosis and Recurrence of Thyroid Cancer Via New Biomarkers, Urinary Exosomal Thyroglobulin and Galectin-3

NCT03488134 · clinicaltrials.gov ↗
COMPLETED
Status
74
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

National Taiwan University Hospital